🇺🇸 FDA

Intelligence · Patent portfolio

Prime Medicine Patents

Full USPTO pharma patent portfolio for Prime Medicine — grant dates, expiration, and drug cross-links.

Patents
127
Expiring ≤24m
1

Quick answer

Prime Medicine has 127 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

Page 3 of 3

  1. US 8614183

    Use of FGFR1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in FGFR2

    Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8580936

    Polynucleotides encoding FGFR1-IIIc ECD fusion proteins

    Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8575312

    Compositions and methods of use for MGD-CSF in disease treatment

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8501191

    FGFR2-IIIb fusion proteins and methods of making them

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8481038

    Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8470789

    Method for inducing and accelerating cells

    Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8445445

    Method of promoting hair growth using FGFR4 extracellular domains

    Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8431532

    FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using same

    Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8404810

    Compositions and methods of use for modulators of polypeptides and polynucleotides in treating breast cancer and melanoma

    Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8394380

    Compositions and methods for alzheimer's disease

    Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8338569

    FGFR extracellular domain acidic region muteins

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8324165

    Compositions for treating arthritis comprising HG1023575 polypeptide

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8206715

    Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8183207

    Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molecules

    Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8178109

    Compositions and methods of use for MGD-CSF in disease treatment

    Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8173134

    ECD carboxy-terminal deletion FGFR4 fusion proteins and methods of producing them

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8168588

    Compositions comprising FGF-9 and betacellulin and methods for treating cardiac conditions

    Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8168751

    Interferon alpha mutant and its polyethylene glycol derivative

    Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8119398

    Adipose-derived stem cells for tissue regeneration and wound healing

    Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8080246

    Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules

    Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8058403

    Antibodies to stromal cell-derived factor-1 polypeptides

    Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7982014

    FGFR3-IIIc fusion proteins

    Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7846892

    Compositions and methods for Alzheimer's disease

    Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7776564

    Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7678890

    Compositions and methods of treating disease with FGFR fusion proteins

    Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7621740

    Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same

    Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7618616

    Skin-protective compositions effective against vesicants and percutaneous chemical agents

    Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7572764

    Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds

    Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7205006

    Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same

    Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 6380167

    Methods for anti-tumor therapy

    Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6274751

    Wax esters enriched in .omega.-3 unsaturated fatty acids, their preparation and their use

    Expires Mon Aug 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Prime Medicine have?

127 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Prime Medicine patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.